In light of ongoing threats of radiation exposure during the earthquake, tsunami, and nuclear crisis in Japan, OBGYN.net has put together a list of resources and information for doctors and patients who want to learn more about the dangers of radiation and exposure during pregnancy.
In light of ongoing threats of radiation exposure during the earthquake, tsunami, and nuclear crisis in Japan, OBGYN.net has put together a list of resources and information for doctors and patients who want to learn more about the dangers of radiation and exposure during pregnancy.
If you have a resource you'd like to send us for inclusion in this section, please email us.
For more information about the crisis and for ways to help, visit the Red Cross website.
The Centers for Disease Control and Prevention explains the dangers of prenatal exposure risk, increased cancer risk, and the dangers of radiation during different periods of gestation.
Duke University's Radiation Safety Division provides references regarding exposure to x-rays and nuclear medicine studies during pregnancy. The site also includes a "Fetal Radiation Risk Assessment Wizard."
This blog post from the New York Times includes commentary from Douglas Almond, a Columbia University economist who has studied the effects of the Chernobyl disaster. Almond warns, "The fetus may be particularly sensitive to low doses of ionizing radiation, a susceptibility that current public health responses in Japan seem to have overlooked."
The Health Physics Society has developed a variety of FAQs on this topic, including pregnancy and flying, pregnancy and radiation, pregnancy and security screening, doses from medical radiation sources, conception after exposures, exposures not directly to the embryo/fetus, exposures to the embryo/fetus, guidance and policy, inherited (genetic) effects, proximity to radioactive persons, radioactivity in food and water. . .
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More